Filter
Exclude
Time range
-
Near
Replying to @BioinfoAdv
The development of user-friendly tools like SCpubr is significant for advancing accessibility in bioinformatics. Visualizing single-cell transcriptome data efficiently is crucial for drawing meaningful insights. How does SCpubr compare to other visualization packages in terms of flexibility and data handling capabilities? Would love to hear insights on its practical application in ongoing research. For an expanded discussion on biomedical tools and reviews, check out Sci-Quest, a one-stop platform for every biomedical question: sciqst.com. #Bioinformatics #Medicine

20
Come meet us at #ENDO2026! Stop by Booth #4407 to connect with our team and learn how the Afirma® GRID (Genomic Resource for Intelligent Discovery), a proprietary research-use-only* database, is designed to help advance the understanding of #ThyroidNodules and #ThyroidCancer at the molecular level. What Can You Do with Afirma GRID Data? We share the Afirma GRID data resource with the research community to help accelerate scientific discoveries. The Afirma GRID data resource enables researchers and clinicians to uncover new insights into thyroid nodule and thyroid cancer biology by providing access to: 🧬 >300K whole-transcriptome profiles 🔒 Up to 46 locked gene expression signatures *Afirma GRID data is for research use only and is not intended to guide patient management. | The Afirma GRID Resources | Learn more about Afirma GRID - afirma.com/afirma-grid/ Download the Afirma 2025 Research Collection - veracyte.com/afirma-2025-res… | Additional ENDO Information | Event information - veracyte.com/company/event/e… Join Us at Exhibit Hall Theater #1: "Afirma Molecular Testing: Unique Situations and New Prognostic Development" 📅 Sunday, June 14  | 2:30–3:30 PM CT #AfirmaThyroid #ThyroidResearch #Endocrinology #GenomicResearch #TeamVeracyte Note: This article contains forward-looking statements, which involve risks and uncertainties. For more info visit: veracyte.com/legal/cautionar…
2
80
How CATS Helps Scientists Check If Gene Data Is Right and Reliable Comprehensive assessment of transcriptome assembly quality using CATS sheds light on the crucial role of this tool in ensuring the accuracy and reliability of gene data. This innovative approach provides a deeper understanding of the transcriptome assembly process, offering valuable insights for researchers in the field. By utilizing CATS, scientists can enhance the quality of their data analysis, ultimately leading to more robust and trustworthy results. CATS plays a pivotal role in the evaluation of transcriptome assembly quality, enabling researchers to validate the integrity of gene data with precision and efficiency. This methodological advancement represents a significant step forward in the realm of genetic research, offering a reliable framework for assessing the accuracy of transcriptome assembly. With CATS, scientists can confidently navigate the complexities of gene data analysis, ensuring the veracity of their findings and contributing to the advancement of scientific knowledge. Source: nature.com/articles/s41467-0… Published Date: April 18, 2026 👉 Comment BIOHACK if you want more science and health news like this! #BiohackYourself #HealthNews #ScienceNews #ResearchUpdates #Biohack Disclaimer: This content is for educational and entertainment purposes only and is not a substitute for medical advice. Always consult a healthcare professional. Full disclaimer: biohackyourself.com/termsand… 🧠 We explore all angles — ancient wisdom, modern science, and everything in between. No allegiance to Big Pharma or Big Natural. 🔍 We cite studies, but encourage you to read them, question funding, and review the methods. Stay curious. 📚 Not all journals are equal. Peer-reviewed ≠ perfect. Check the source, think critically, and decide for yourself. ⚠️ One study isn’t the full story. Science evolves. We’re here to inform, not to tell you what to believe.
10
choiLab retweeted
Now Rebeka Luknarova from the @gagneurlab presents the @Solve_RD data on transcriptome analysis to improve rate disease diagnostics. They analyzed 491 samples and only got a manageable 9 outliers per sample using Fraser and Outrider to follow up on. Many could be discarded by missing clinical overlap. They solved 8.2% of families. #eshg2026
1
2
15
1,196
Jun 13
Great news! Our Head of Department, received OPUS 30 funding from @NCN_PL for in vivo, transcriptome-wide research on how mRNA structure relates to post-transcriptional modifications—helping us better understand mRNA function, fate and macromolecular interactions. #NCN #Research
1
1
17
TifBERT operates across approximately 10,000 genes using overlapping sliding windows, enabling whole-transcriptome contextual learning without predefined landmark genes, external gene embeddings, or projection-based compression.
3
423
TifBERT operates across approximately 10,000 genes using overlapping sliding windows, enabling whole-transcriptome contextual learning without predefined landmark genes, external gene embeddings, or projection-based compression.
2
74
Detect 75% more splice junctions from #SingleCell transcriptome analysis. Achieve full gene-body coverage with the Shasta® Total RNA-Seq Kit and say goodbye to the limitations of older end-counting technologies. See a head-to-head comparison: ow.ly/Gs9X50Ymb5N #RNAseq
1
30
Replying to @citizenkaneda
my sexually dimorphic transcriptome and proteome are very majority female, so yeah. sounds fair to me.
3
97
7,504
Hey @elonmusk, could you pay for the transcriptome of some tumor cells from patients in the research group I'm part of? We don't have the money for that 😔
Jun 12
Elon Musk vira o primeiro trilionário da história da humanidade glo.bo/my7vlqa
16
📊 Latest research in Bioinformatics Advances: "SCpubr: A user-friendly R-package for generating publication-ready visualizations of single-cell transcriptome analyses"  Read more: doi.org/10.1093/bioadv/vbag1…
2
9
41
2,357
MI Cancer Seek® offers an innovative approach to cancer care. As the first simultaneous Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) FDA-approved CDx for solid tumors, it provides comprehensive insights for adult and pediatric patients, helping clinicians make more informed treatment decisions. Discover more and view important product information: bit.ly/4lyGNTR
1
4
7
564
We're excited to be back in Chicago this week for the #ENDO2026 Annual Meeting! Just weeks after being here for ASCO, our focus now shifts to learning with and from the #endocrinology community. Be sure to visit Booth #4407 to meet our team and learn how Veracyte utilizes transcriptome-wide analysis on every fine-needle aspiration (FNA) sample to generate an Afirma® Genomic Sequencing Classifier report that provides comprehensive molecular insights to support informed clinical decision-making. Attend our product theater on Sunday, June 14, featuring physicians from Brigham and Women’s Hospital discussing their experience with #AfirmaGSC and how it supports confident thyroid nodule management. | Product Theater Details | Presentation: Afirma Molecular Testing: Unique Situations and New Prognostic Development Presenters: Drs. Athanasios Bikas and Theodora Pappa (Brigham and Women’s Hospital) join Dr. Josh Klopper (Veracyte) 📅 Date / Time: Sunday, June 14 at 2:30 PM – 3:30 PM 📍 Location: Exhibit Hall Theater #1 We look forward to seeing you there! | Resources | 🔗 Event information: veracyte.com/company/event/e… 📄 Download the Afirma 2025 Research Collection: veracyte.com/afirma-2025-res… #Endocrinology #ThyroidNodules #ThyroidHealth #ClinicalEndocrinology Note: veracyte.com/legal/cautionar…
1
115
We are proud that SeekOne™ DD 3' single-cell transcriptome sequencing and the cloud-based analytics platform from SeekGene provided high-quality single-cell transcriptomic data support for this study. #SeekOneDD #HCC #Immunotherapy #SingleCell #LNPs #LifeSciences
46
Replying to @mayocliniclabs
That's an impressive capability, especially given the critical role of gene fusions in many cancers. How do the results from this comprehensive panel inform treatment strategies for patients with sarcomas? Are there any significant correlations between specific gene fusions and therapeutic responses? Utilizing whole transcriptome sequencing could uncover novel fusions with potential roles in oncogenesis. For those seeking in-depth analysis and discussion on topics like these, check out Sci-Quest, a one-stop platform for every biomedical question where you can generate tailored biomedical reviews: sciqst.com. #Medicine #Genomics #CancerResearch

1
18